ShanX Medtech
Develops in-vitro diagnostic platforms for rapid antimicrobial susceptibility testing.
About
ShanX Medtech is developing novel diagnostics, specifically an ultra-rapid Antimicrobial Susceptibility Testing (AST) platform. This platform aims to provide sample-to-result turnaround times as fast as 1 hour, significantly reducing the current 2-7 day wait for AST results. By enabling faster identification of effective antibiotics, ShanX Medtech serves clinicians and patients by improving treatment outcomes and combating Antimicrobial Resistance. Teams look it up for HealthTech, Biotechnology, Diagnostics.
Frequently asked
What does ShanX Medtech do?
ShanX Medtech is a HealthTech company that offers Platform. Teams look it up for Biotechnology, Diagnostics, MedTech. It is based in San Diego, United States and was founded in 2019. Public records show about 16 people and $28M raised. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has ShanX Medtech raised?
ShanX Medtech has raised a total of $28M in funding. The most recent round on record is Grant.
Where is ShanX Medtech headquartered?
ShanX Medtech is headquartered in San Diego, United States.
When was ShanX Medtech founded?
ShanX Medtech was founded in 2019.
What industry does ShanX Medtech operate in?
ShanX Medtech operates in HealthTech, Biotechnology, Diagnostics, MedTech, In-Vitro Diagnostics.
How many employees does ShanX Medtech have?
ShanX Medtech has approximately 16 people on record.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.